Persistence Market Research is released new forthcoming report on title "Melanoma Therapeutics Market: Global Industry Analysis and Forecast to 2020".
New York, NY -- (SBWIRE) -- 11/21/2014 -- Market for skin diseases and treatment are increasing significantly due to the rising prevalence of skin problems such as skin cancer, skin infections and skin allergies. Skin cancer may be of three types: basal cell carcinoma, squamous cell carcinoma and melanoma. Melanoma refers to the type of skin cancer which is formed due to pigment forming cells in the skin. It is more common in areas with sunny climate and is most serious all other types of skin cancer. Main causes of melanoma are UV radiations. However, it may also be caused due to genetic reasons. Various treatment options available for melanoma include surgery, radiation therapy and pharmacotherapy. Various therapies available in the market for the treatment of melanoma are adjuvant therapy, immunotherapy and chemotherapy. The global market for melanoma therapeutics is increasing at a significant rate due to increase in the prevalence of melanoma and improvement in the healthcare facilities. In addition, government initiatives and technical advancements in the field are helping in the growth of melanoma therapeutics market.
Buy Full Report:
North America dominates the global market for melanoma therapeutics due to increasing prevalence on melanoma cases and technical advancements in the region. In addition, increased awareness and improved healthcare facilities are driving the North American market for melanoma therapeutics. Asia, followed by the Europe, is expected to experience high growth rate in the next few years in melanoma therapeutics market. China and India are expected to be the fastest growing melanoma therapeutics markets in Asia region. This is due to large population base and increasing prevalence of melanoma cases in these countries. Some of the key driving forces for melanoma therapeutics market in emerging countries are increasing awareness and improved healthcare facilities.
Increased awareness, technological advancement in field and high adoption rate of this therapeutics among the patients has driven the global melanoma therapeutics market. In addition, government initiatives in the field have driven the market for melanoma therapeutics. However, factors such as lack of awareness in some developing regions and high cost involved are restraining the global melanoma therapeutics market from growing. In addition, economic crisis followed with regulatory issues are restraining the melanoma therapeutics market from growing.
Growing demographics and economies in the developing countries such as India and China are expected to offer good opportunities for the global melanoma therapeutics market. Innovation of some new medications with focus on better efficiency is expected to offer good opportunity for the global melanoma therapeutics market. Availability of new drugs, with more efficacies, in the pipeline is expected to offer good opportunities for the global market for melanoma therapeutics. However, less reluctance among people from undergoing the therapies and surgeries is one of the major challenges faced by the global market for melanoma therapeutics. One of the latest trends that have been observed in the global melanoma therapeutics includes the introduction of combination therapies for the treatment of melanoma. Some of the major companies dealing in the global market for melanoma therapeutics are Bristol-Myers Squibb Co., Merck and Co. Inc., and F. Hoffmann-La Roche Ltd. Some other companies having significant presence in the global market for melanoma therapeutics are AB Science S.A., Amgen Inc., Celgene Corp., Daiichi Sankyo Co., Eisai Co. Ltd., GlaxoSmithKline plc, Pfizer Inc., and Vical Inc.
Request Full Toc:
About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.